MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
The PVSS
An update of the history and future of the Peripheral Vascular Surgery Society.
By Lewis B. Schwartz, MD, and Robert G. Scribner, MD
Efemoral Medical’s Bioresorbable Vascular Scaffold Gains FDA Breakthrough Device Designation
February 14, 2024—The Efemoral Vascular Scaffold System (EVSS) has been granted FDA Breakthrough Device status for treating de novo or restenotic infrapopliteal artery lesions in patients with chronic limb-threatening ischemia (CLTI).
Efemoral Medical Awarded Phase II SBIR Grant From NIH for Vascular Scaffold System
September 22, 2022—Efemoral Medical, developer of interventional bioresorbable therapies, announced that it has been awarded a phase II Small Business Innovation Research (SBIR) grant, which is supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH).
Sponsored by Medtronic
Applications for the MVP™ Microvascular Plug
With John J. Park, MD, PhD; Michael Cohn, MD, MS; and Andrew Lewis, MD
Atherectomy in the Superficial Femoral Artery
An evidence-based approach for device selection, ideal applications, and cases to avoid.
By Wael F. Al-Husami, MD, FACC; Mohammed W. Akhter, MD; and Lawrence A. Garcia, MD, FACC, FAHA
